how perjeta (pertuzumab) is used to treat her2-positive breast cancer
Published 6 years ago • 13K plays • Length 3:37Download video MP4
Download video MP3
Similar videos
-
8:31
trastuzumab (herceptin) and pertuzumab (perjeta) for breast cancer: what you need to know
-
1:16
the optimal duration of pertuzumab treatment for patients with her2 breast cancer
-
3:50
herceptin (trastuzumab) for her2-positive breast and stomach cancer
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
2:12
dr. pegram on pertuzumab and trastuzumab in breast cancer
-
1:51
dr. kolberg on cost-effectiveness of pertuzumab in her2-positive breast cancer
-
14:09
#pertuzumab | uses, dosage, side effects & mechanism | perjeta
-
4:29
pertuzumab, trastuzumab and cyclophosphamide in older patients with her2 breast cancer
-
6:08
first-line treatment of her2-positive metastatic breast cancer
-
0:57
dr. mittendorf on the impact of pertuzumab in her2 breast cancer
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
2:31
dr. peter beitsch on pertuzumab in luminal subtype breast cancer
-
3:20
dr. hurvitz on eliminating anthracyclines in her2 breast cancer treatment
-
13:08
her2 positive breast cancer: everything you must know
-
3:21
how breast cancer treatment kadcyla (t-dm1) works
-
6:00
frontline pertuzumab for metastatic breast cancer
-
7:30
aphinity trial in her2 breast cancer
-
1:59
adapt: de-escalated neoadjuvant pertuzumab trastuzumab with or without paclitaxel in hr-/her2 ebc